When you lift weights, a specific protein in your muscles (4E-BP1) temporarily stops being activated in one way, even though another related protein (mTOR) stays just as active as before—this suggests that mTOR might be controlling 4E-BP1 through a different, hidden method.

In healthy human adults, measure 4E-BP1 Thr37/46 and mTOR Ser2448 phosphorylation via muscle biopsies before, immediately after, and 30 minutes post-resistance exercise (e.g., 4 sets of 8–10 reps at 80% 1RM), compared to pre-exercise baseline, to confirm transient reduction in 4E-BP1 phosphorylation without change in mTOR Ser2448 phosphorylation.

In human primary myotubes, induce resistance exercise-like mechanical stress via stretch or electrical pulse stimulation, then measure 4E-BP1 Thr37/46 and mTOR Ser2448 phosphorylation; use mTOR Ser2448-specific inhibitors to test if 4E-BP1 dephosphorylation still occurs despite blocked Ser2448 phosphorylation.

In transgenic mice with a non-phosphorylatable mTOR Ser2448 mutation (S2448A), perform resistance exercise (e.g., ladder climbing with load) and compare 4E-BP1 Thr37/46 phosphorylation to wild-type mice to determine if mTOR Ser2448 phosphorylation is required for 4E-BP1 regulation.

Perform unbiased phosphoproteomics on human muscle biopsies before and after resistance exercise to identify all phosphorylation changes in 4E-BP1 and mTOR pathway components, specifically testing whether non-canonical sites on mTOR or other kinases (e.g., AMPK, GSK3) correlate with 4E-BP1 Thr37/46 dephosphorylation.

Compare 4E-BP1 Thr37/46 and mTOR Ser2448 phosphorylation responses to a standardized resistance exercise bout between resistance-trained and untrained individuals to determine if the dissociation pattern is consistent across training status.